NIGP 94834: Disease Prevention and Control Services, Contagious (see 948-92 for Vaccination Services)

NIGP 94834 Disease Prevention And Control Services, Contagious (Item) encompasses mosquito control operations, communicable disease isolation and outpatient services, occupational health surveillance for disease exposure, and opioid overdose prevention — grounded in what state and local health departments, county health systems, and municipal public health divisions are actually soliciting. State and local buyers under this code include county health departments (Solano County, Santa Clara County Health System, Utah Department of Health & Human Services), city public health offices (City of Arlington, Texas), state agencies (State of Florida Department of Children and Families, Oregon State Police, Harris Center for Mental Health and IDD), and specialty healthcare facilities. Recent solicitations span mosquito control (Arlington, Texas RFP for annual surveillance, trap monitoring, and targeted larvicide and adulticide application), emergency opioid antagonist supply and distribution (Florida Department of Children and Families RFP for multiple naloxone formulations with two-day statewide delivery to 1,500 authorized distributors), tuberculosis isolation and outpatient services (Utah DHHS RFI for dedicated negative-pressure isolation capacity and multi-disciplinary TB care), tuberculosis housing for individuals experiencing homelessness (Utah sole-source award to Wasatch Homeless Health Care), and occupational health and medical surveillance for disease exposure management (Oregon State Police RFQ for bloodborne pathogen training, vaccination, tuberculosis screening, and fitness-for-duty examinations across a 6-year term with up to $250,000 compensation).

Geographic activity concentrates in Texas, Florida, Utah, Oregon, and California, with Texas and Utah showing multiple active procurements. The City of Arlington, Texas posted RFP 270015 for mosquito control services due October 22, 2026, requiring qualified pesticide applicator experience with CDC, EPA, and Texas DSHS guidelines. The State of Florida Department of Children and Families posted RFP 16548 (with five addenda issued through September 21, 2026) for emergency opioid antagonist products including intranasal, prefilled-syringe, auto-injector, and vial formulations with responses due November 10, 2026 and award anticipated October 27, 2026; this vehicle awards to one or more vendors per product line and requires USA manufacturing and assembly with demonstrated capacity to ship 65,000 to 150,000 units monthly to distributed networks. The Oregon State Police RFQ S2570000017070, posted May 29, 2026, solicits occupational health and medical surveillance services due July 3, 2026 under a six-year contract with a $250,000 not-to-exceed ceiling. The Utah Department of Health & Human Services issued DHHS26088, a non-binding RFI due May 22, 2026, to gather capacity information on tuberculosis isolation and outpatient services from qualified healthcare facilities statewide before any formal procurement process; responses inform future bidding strategy but generate no contract award.